Objective We aimed to investigate the prevalence of depression in cancer patients assessed
by diagnostic interviews and self‐report instruments, and to study differences in prevalence …

Depression is a common comorbidity in cancer cases, affecting> 10% of patients. A cancer
diagnosis is life‑changing, and is a source of considerable psychological and emotional …

Cancer patients often develop chronic, clinically significant symptoms of depression and
anxiety. Previous studies suggest that psilocybin may decrease depression and anxiety in …

Background Substantial uncertainty exists about prevalence of mood disorders in patients
with cancer, including those in oncological, haematological, and palliative-care settings. We …

Background Major depression is an important complication of cancer. However, reliable
data are lacking for the prevalence of depression in patients with cancer in different primary …

Background Major depression and other depressive conditions are common in people with
cancer. These conditions are not easily detectable in clinical practice, due to the overlap …

Background Symptoms of depression and anxiety are common in patients with lung cancer
and may produce an impact on both health-related quality of life (HRQL) and survival. The …

OBJECTIVE: While many breast cancer patients experience “normal” distress, there is a
subset who experience clinically significant depression. We examined the current …

Background Depression has substantial effects on cancer patients' quality of life. Estimates
of its prevalence vary widely. We aimed to systematically review published studies to obtain …

Background Medical conditions are often complicated by major depression, with consequent
additional impairment of quality of life. We aimed to compare the effectiveness of an …